FGA

Chr 4ARAD

fibrinogen alpha chain

Also known as: AMYLD2, Fib2

This gene encodes the alpha subunit of the coagulation factor fibrinogen, which is a component of the blood clot. Following vascular injury, the encoded preproprotein is proteolytically processed by thrombin during the conversion of fibrinogen to fibrin. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. [provided by RefSeq, Jan 2016]

Primary Disease Associations & Inheritance

Afibrinogenemia, congenitalMIM #202400
AR
Amyloidosis, hereditary systemic 2MIM #105200
AD
Dysfibrinogenemia, congenitalMIM #616004
AD
Hypodysfibrinogenemia, congenitalMIM #616004
AD
UniProtCongenital afibrinogenemia
374
ClinVar variants
90
Pathogenic / LP
0.00
pLI score
2
Active trials
Clinical Summaryβ€” FGA
🧬
Gene-Disease Validity (ClinGen)
congenital fibrinogen deficiency Β· SDDefinitive

Definitive β€” sufficient evidence for diagnostic panels

⚑
Population Constraint (gnomAD)
Low constraint (pLI 0.00) β€” loss-of-function variants are relatively tolerated in the population.
πŸ“‹
ClinVar Variants
90 Pathogenic / Likely PathogenicΒ· 220 VUS of 374 total submissions
πŸ’Š
Clinical Trials
2 active or recruiting trials β€” potential therapeutic options may be available
Some data sources returned errors (1)

pubmed: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi

Population Genetics & Constraint

gnomAD v4 β€” loss-of-function & missense intolerance

Tolerant β€” LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE β€” the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
1.02LOEUF
pLI 0.000
Z-score 1.46
OE 0.73 (0.53–1.02)
Tolerant

Highly tolerant β€” LoF variants common in population

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
-0.67Z-score
OE missense 1.09 (1.01–1.17)
498 obs / 457.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≀ 0.35 = strong LoF constraint signal.0.73 (0.53–1.02)
0≀0.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≀ 0.6 = fewer missense variants than expected by chance.1.09 (1.01–1.17)
0≀0.61.4
Synonymous OE?Control metric β€” synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.11
0≀1.21.6
LoF obs/exp: 25 / 34.2Missense obs/exp: 498 / 457.6Syn Z: -1.12

ClinVar Variant Classifications

374 submitted variants in ClinVar

Classification Summary

Pathogenic53
Likely Pathogenic37
VUS220
Likely Benign29
Benign18
Conflicting17
53
Pathogenic
37
Likely Pathogenic
220
VUS
29
Likely Benign
18
Benign
17
Conflicting

Curated Variants Distribution

Classified variants from ClinVar Β· 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
10
6
37
0
53
Likely Pathogenic
19
7
11
0
37
VUS
2
202
8
8
220
Likely Benign
0
6
5
18
29
Benign
1
2
14
1
18
Conflicting
β€”17
Total322237527374

LoF = frameshift, stop gained/lost, canonical splice Β· Counts from ClinVar esearch Β· Updated hourly

View in ClinVar β†’

Protein Context β€” Lollipop Plot

FGA Β· protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM β€” Genotype-Phenotype Relationships

1 OMIM entry

Afibrinogenemia, congenital

MIM #202400

Molecular basis of disorder known

Autosomal recessive

Amyloidosis, hereditary systemic 2

MIM #105200

Molecular basis of disorder known

Autosomal dominant

Dysfibrinogenemia, congenital

MIM #616004

Molecular basis of disorder known

Autosomal dominant

Hypodysfibrinogenemia, congenital

MIM #616004

Molecular basis of disorder known

Autosomal dominant